Hosted on MSN9h
Studies Point to Several Options for Ulcerative Colitis After Anti-TNF Failure
Clinical outcomes for ulcerative colitis patients with a prior anti-TNF therapy failure appeared similar with ustekinumab ...
emjreviews.com18h
Ulcerative Colitis and Clostridioides difficile: New Insights into Infection Risk
A study revealed that IBD patients, particularly those with ulcerative colitis and multiple biologic treatments, face an ...
PipelineReview.com1d
Accropeutics Announces First Patient Dosed in Phase Ib Study of RIPK2 Inhibitor AC-101
NEW YORK, NY, USA I 13, 2025 I Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel ...
Investor's Business Daily on MSN2d
AnaptysBio Whipsaws On Promising Results In Rheumatoid Arthritis Treatment
AnaptysBio stock whipsawed Wednesday despite promising results for its experimental rheumatoid arthritis treatment.
BioWorld4d
PALI-2108 colon-activated prodrug prevents ulcerative colitis progression
Ulcerative colitis is a chronic, immune-mediated disorder of the colon and rectum characterized by mucosal inflammation that damages the bowel wall surface. Current therapeutic options include ...
Palisade Bio presents preclinical data of PALI-2108
Palisade Bio (PALI) announced the presentation of positive preclinical data from PALI-2108, an orally administered, colon-specific ...
Scientists peel away the mystery of JAK enzymes, which play roles in everything from eczema to ulcerative colitis
Pharmaceutical ads are difficult to avoid in American television programming and a growing number of them promote a class of ...